SIH Partners’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
SIH Partners's VKTX Position: Q3 2026 in Review
SIH Partners opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 177,889 shares worth $5.8M. The stake represents 0.06% of the portfolio and ranks #98 among its holdings.
439 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- SIH Partners held 177,889 shares of Viking Therapeutics worth $5.8M as of Q3 2026.
- Viking Therapeutics was a new SIH Partners position in Q3 2026.
- Viking Therapeutics made up 0.06% of SIH Partners's portfolio in Q3 2026, its #98 holding.
- 439 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on SIH Partners's 13F filing for Q3 2026, filed 16 Nov 2026.